Ordered mesoporous magnesium silicate with uniform nanochannels as a drug delivery system: The effect of calcination temperature on drug delivery rate
Source abstract
Abstract
Abstract Magnesium silicate nanostructured biomaterials with good bioactivity, biocompatibility, and mechanical properties are promising for applications in various biomedical fields. Herein, ordered mesoporous magnesium silicate (OMMS) was prepared by sol-gel method and the effect of calcination temperature to evaluate its application as ibuprofen (IBU) drug delivery system was investigated. The synthesized powders were calcined at 350, 550, 750 °C and characterized by X-ray diffraction (XRD), Fourier transmission infrared spectroscopy (FTIR), N2 adsorption–desorption, and transmission electron microscopy (TEM). All samples demonstrated mesoporous characteristics with high specific surface area ranging from 386 to 504 m2/g. It was found that the sample calcined at 350 °C showed the slowest drug release rate among all samples, which is due to smaller pore size and the existence of larger amounts of intrawall microporosity. Cytotoxicity of MG63 osteoblast cell line was investigated by MTT assay, indicating no toxicity for IBU- loaded sample calcined at 550 °C with a concentration less than 10 mg/ml. This study has revealed that altering the calcination temperature may change the drug delivery behavior of OMMS by influencing textural properties and suggests OMMS as a promising local drug delivery system in bone tissue engineering applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Layered Double Hydroxides Synthesis and Applications · Mesoporous Materials and Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Vallet-Regi · 2014 · 343
2. Mesoporous silica nanoparticles for drug delivery and biosensing applications10.1002/adfm.200601191 ↗
3. In situ microemulsion synthesis of hydroxyapatite-MgFe2O4 nanocomposite as a magnetic drug delivery system10.1016/j.msec.2016.07.028 ↗
4. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system10.1016/j.jconrel.2005.11.002 ↗
5. A new method to produce macropores in calcium–phosphate cements10.1016/S0142-9612(02)00101-1 ↗
6. Bioceramics for drug delivery10.1016/j.actamat.2012.10.039 ↗
7. In vitro degradability, bioactivity and cell responses to mesoporous magnesium silicate for the induction of bone regeneration10.1016/j.colsurfb.2014.04.010 ↗
8. In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite10.1016/j.biomaterials.2010.06.047 ↗
9. Stability of layered aluminum and magne-sium organosilicates10.1016/j.micromeso.2007.05.047 ↗
10. Surfactant-assisted sol–gel synthesis of forsterite nanoparticles as a novel drug delivery system10.1016/j.msec.2015.09.020 ↗
11. Profiles of drug substances
12. Tissue engineering scaffolds of mesoporous magnesium silicate and poly(e-caprolactone)–poly(ethylene glycol)–poly (e-caprolactone) composite
13. Colloids: applications and remaining challenges
14. Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors10.2147/IJN.S59040 ↗
15. Ibuprofen release from porous hydroxyapatite tablets10.1016/j.ceramint.2011.02.021 ↗
16. Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization10.1016/j.cej.2007.07.078 ↗
17. Preparation of spherical MCM-41 molecular sieve at room temperature: influence of the synthesis conditions in the structural properties10.1016/j.ceramint.2012.05.007 ↗
18. Synthesis and luminescence properties of YAG: Ce nanopowder prepared by the Pechini method10.1016/j.apt.2011.04.006 ↗
19. Reverse microemulsion synthesis and characterization of CaSnO3 nanoparticles10.1016/j.ceramint.2014.02.037 ↗
20. Solvothermal synthesis of copper nanoparticles loaded on multi-wall carbon nanotubes as catalyst for thermal decomposition of ammonium perchlorate
21. Reverse microemulsion synthesis of CeO2 nanopowder using polyoxyethylene(23)lauryl ether as a surfactant10.1016/j.ceramint.2014.01.086 ↗
22. Influence of different structured channels of mesoporous silicate on the controlled ibuprofen delivery10.1016/j.matchemphys.2012.05.059 ↗
23. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity10.1351/pac198557040603 ↗
24. Stepwise functionalization of mesoporous crystalline silica materials10.1016/S1387-1811(98)00173-5 ↗
25. A new property of MCM 41: drug delivery system10.1021/cm0011559 ↗
26. Structure and surface and catalytic properties of Mg-Al basic oxides10.1006/jcat.1998.2161 ↗
27. Effect of basic properties of MgO on the heterogeneous synthesis of flavanone10.1016/j.apcata.2006.01.007 ↗
28. Hierachically nanostructured mesoporous spheres of calcium silicate hydrate: surfactant-free sonochemical synthesis and drug-delivery system with ultrahigh drug-loading capacity10.1002/adma.200903020 ↗
29. Influence of pore size of MCM-41 matrices on drug delivery rate10.1016/j.micromeso.2003.12.012 ↗
30. Influence of microporosity in SBA-15 on the release properties of anticancer drug dasatinib10.1039/C4TB00418C ↗
31. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials10.1021/ja062286z ↗
32. Effect of amine functionalization of spherical MCM-41 and SBA-15 on controlled drug release
33. Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range10.1016/j.micromeso.2011.07.023 ↗
34. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs10.1016/0168-3659(87)90034-4 ↗
35. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation10.1016/0378-5173(89)90306-2 ↗
36. In vitro evaluation of (S)- ibuprofen toxicity on joint cells and explants of cartilage and synovial membrane10.1016/j.tiv.2011.06.018 ↗
37. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer10.1158/1078-0432.CCR-04-1696 ↗
38. Investigation on bioactivity and cytotoxicity of mesoporous nano-composite MCM-48/hydroxyapatite for ibuprofen drug delivery10.1016/j.ceramint.2013.12.079 ↗